Organon Total Assets from 2010 to 2024
| OGN Stock | USD 15.28 0.39 2.62% |
Total Assets | First Reported 2010-12-31 | Previous Quarter 12.1 B | Current Value 11.9 B | Quarterly Volatility 529.2 M |
Check Organon financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Organon's main balance sheet or income statement drivers, such as Tax Provision of 90.2 M, Interest Expense of 553.4 M or Selling General Administrative of 1.3 B, as well as many indicators such as Price To Sales Ratio of 0.77, Dividend Yield of 0.0839 or Days Sales Outstanding of 60.09. Organon financial statements analysis is a perfect complement when working with Organon Valuation or Volatility modules.
Organon | Total Assets |
Latest Organon's Total Assets Growth Pattern
Below is the plot of the Total Assets of Organon Co over the last few years. Total assets refers to the total amount of Organon assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Organon books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Organon's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Organon's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 12.06 B | 10 Years Trend |
|
Total Assets |
| Timeline |
Organon Total Assets Regression Statistics
| Arithmetic Mean | 10,737,988,889 | |
| Geometric Mean | 10,726,514,273 | |
| Coefficient Of Variation | 4.93 | |
| Mean Deviation | 366,248,889 | |
| Median | 10,494,000,000 | |
| Standard Deviation | 529,202,547 | |
| Sample Variance | 280055.3T | |
| Range | 1.6B | |
| R-Value | 0.68 | |
| Mean Square Error | 162000.7T | |
| R-Squared | 0.46 | |
| Significance | 0.01 | |
| Slope | 80,506,548 | |
| Total Sum of Squares | 3920774.7T |
Organon Total Assets History
Other Fundumenentals of Organon
Organon Total Assets component correlations
Click cells to compare fundamentals
About Organon Financial Statements
Organon investors utilize fundamental indicators, such as Total Assets, to predict how Organon Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Assets | 12.1 B | 11.9 B | |
| Intangibles To Total Assets | 0.43 | 0.53 |
Pair Trading with Organon
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Organon position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will appreciate offsetting losses from the drop in the long position's value.Moving together with Organon Stock
Moving against Organon Stock
| 0.89 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
| 0.88 | GILD | Gilead Sciences | PairCorr |
| 0.85 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.67 | VRDN | Viridian Therapeutics | PairCorr |
| 0.63 | KZR | Kezar Life Sciences | PairCorr |
The ability to find closely correlated positions to Organon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Organon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Organon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Organon Co to buy it.
The correlation of Organon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Organon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Organon moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Organon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Organon Correlation against competitors. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organon. If investors know Organon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organon listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.081 | Dividend Share 1.12 | Earnings Share 5.05 | Revenue Per Share 24.984 | Quarterly Revenue Growth 0.041 |
The market value of Organon is measured differently than its book value, which is the value of Organon that is recorded on the company's balance sheet. Investors also form their own opinion of Organon's value that differs from its market value or its book value, called intrinsic value, which is Organon's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organon's market value can be influenced by many factors that don't directly affect Organon's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Organon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.